I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78%
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InDex Pharmaceuticals Holding AB
Cash Equivalents Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Cash Equivalents
kr882.2m
CAGR 3-Years
23%
CAGR 5-Years
77%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Cash Equivalents
kr2.6B
CAGR 3-Years
83%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Cash Equivalents
kr170m
CAGR 3-Years
-49%
CAGR 5-Years
34%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Cash Equivalents
kr111.3m
CAGR 3-Years
-26%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Cash Equivalents
kr60.6m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Cash Equivalents?
Cash Equivalents
882.2m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Cash Equivalents amounts to 882.2m SEK.

What is InDex Pharmaceuticals Holding AB's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
77%

Over the last year, the Cash Equivalents growth was 114%. The average annual Cash Equivalents growth rates for InDex Pharmaceuticals Holding AB have been 23% over the past three years , 77% over the past five years .

Back to Top